Oncology Peer Review On-The-Go: Primary Focal Therapy for Localized Prostate Cancer
CancerNetwork® spoke with 2 experts to learn more about focal therapy and its role in treating localized prostate cancer moving forward.
This episode of "Oncology Peer Review On-The-Go" focuses on a review article from the May issue of the journal ONCOLOGY® titled “Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature.” Corresponding author Sudhir Isharwal, MD, an assistant professor in the Department of Urology at Oregon Health & Science University in Portland, Oregon, discussed the emergence of focal therapies over the last few years for the treatment of patients with localized prostate cancer. This literature review investigated some of the advantages and drawbacks of various therapeutic models in this space.
The perspective for this article was written by Thomas Polascik, MD, a professor of Surgery/Urology and director of Focal Therapy at the Duke Cancer Center of Duke Medical Center in Durham, North Carolina. Polascik discussed the perspective he wrote for this article, titled “Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright.” He touched on all aspects of focal therapy, including history, potential hurdles, and patient selection and surveillance, among other things.
Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
